Mostrar el registro sencillo del ítem

dc.contributor.author
Higareda Almaraz, Juan Carlos  
dc.contributor.author
Ruiz Moreno, Juan S.  
dc.contributor.author
Klimentova, Jana  
dc.contributor.author
Barbieri, Daniela  
dc.contributor.author
Salvador Gallego, Raquel  
dc.contributor.author
Ly, Regina  
dc.contributor.author
Valtierra Gutierrez, Ilse A.  
dc.contributor.author
Dinsart, Christiane  
dc.contributor.author
Rabinovich, Gabriel Adrián  
dc.contributor.author
Stulik, Jiri  
dc.contributor.author
Rösl, Frank  
dc.contributor.author
Rincon Orozco, Bladimiro  
dc.date.available
2017-09-05T17:55:11Z  
dc.date.issued
2016-08-24  
dc.identifier.citation
Higareda Almaraz, Juan Carlos; Ruiz Moreno, Juan S.; Klimentova, Jana; Barbieri, Daniela; Salvador Gallego, Raquel; et al.; Systems-level effects of ectopic galectin-7 reconstitution in cervical cancer and its microenvironment; BioMed Central; Bmc Cancer; 16; 24-8-2016; 680-689  
dc.identifier.issn
1471-2407  
dc.identifier.uri
http://hdl.handle.net/11336/23687  
dc.description.abstract
ckgroundGalectin-7 (Gal-7) is negatively regulated in cervical cancer, and appears to be a link between the apoptotic response triggered by cancer and the anti-tumoral activity of the immune system. Our understanding of how cervical cancer cells and their molecular networks adapt in response to the expression of Gal-7 remains limited.MethodsMeta-analysis of Gal-7 expression was conducted in three cervical cancer cohort studies and TCGA. In silico prediction and bisulfite sequencing were performed to inquire epigenetic alterations. To study the effect of Gal-7 on cervical cancer, we ectopically re-expressed it in the HeLa and SiHa cervical cancer cell lines, and analyzed their transcriptome and SILAC-based proteome. We also examined the tumor and microenvironment host cell transcriptomes after xenotransplantation into immunocompromised mice. Differences between samples were assessed with the Kruskall-Wallis, Dunn?s Multiple Comparison and T tests. Kaplan?Meier and log-rank tests were used to determine overall survival.ResultsGal-7 was constantly downregulated in our meta-analysis (p < 0.0001). Tumors with combined high Gal-7 and low galectin-1 expression (p = 0.0001) presented significantly better prognoses (p = 0.005). In silico and bisulfite sequencing assays showed de novo methylation in the Gal-7 promoter and first intron. Cells re-expressing Gal-7 showed a high apoptosis ratio (p < 0.05) and their xenografts displayed strong growth retardation (p < 0.001). Multiple gene modules and transcriptional regulators were modulated in response to Gal-7 reconstitution, both in cervical cancer cells and their microenvironments (FDR < 0.05 %). Most of these genes and modules were associated with tissue morphogenesis, metabolism, transport, chemokine activity, and immune response. These functional modules could exert the same effects in vitro and in vivo, even despite different compositions between HeLa and SiHa samples.ConclusionsGal-7 re-expression affects the regulation of molecular networks in cervical cancer that are involved in diverse cancer hallmarks, such as metabolism, growth control, invasion and evasion of apoptosis. The effect of Gal-7 extends to the microenvironment, where networks involved in its configuration and in immune surveillance are particularly affected.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
BioMed Central  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by/2.5/ar/  
dc.subject
Galectin-7  
dc.subject
Cervical Cancer  
dc.subject
Immune System  
dc.subject
Tumor Microenvironment  
dc.subject.classification
Bioquímica y Biología Molecular  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.subject.classification
Patología  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.subject.classification
Inmunología  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Systems-level effects of ectopic galectin-7 reconstitution in cervical cancer and its microenvironment  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2017-08-31T20:29:24Z  
dc.identifier.eissn
1471-2407  
dc.journal.volume
16  
dc.journal.pagination
680-689  
dc.journal.pais
Reino Unido  
dc.journal.ciudad
Londres  
dc.description.fil
Fil: Higareda Almaraz, Juan Carlos. German Cancer Research Center DKFZ; Alemania. Helmholtz Zentrum München; Alemania  
dc.description.fil
Fil: Ruiz Moreno, Juan S.. German Cancer Research Center DKFZ; Alemania. Infectious Diseases and Respiratory Medicine; Alemania  
dc.description.fil
Fil: Klimentova, Jana. University of Defence Czech Republic; Eslovaquia  
dc.description.fil
Fil: Barbieri, Daniela. German Cancer Research Center DKFZ; Alemania. Policlinico S.Orsola Malpighi; Italia  
dc.description.fil
Fil: Salvador Gallego, Raquel. German Cancer Research Center DKFZ; Alemania. Eberhard Karls Universität Tübingen ; Alemania  
dc.description.fil
Fil: Ly, Regina. German Cancer Research Center DKFZ; Alemania  
dc.description.fil
Fil: Valtierra Gutierrez, Ilse A.. Ludwig Maximilians Universität München; Alemania  
dc.description.fil
Fil: Dinsart, Christiane. German Cancer Research Center DKFZ; Alemania  
dc.description.fil
Fil: Rabinovich, Gabriel Adrián. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina  
dc.description.fil
Fil: Stulik, Jiri. University of Defence Czech Republic; Eslovaquia  
dc.description.fil
Fil: Rösl, Frank. German Cancer Research Center DKFZ; Alemania  
dc.description.fil
Fil: Rincon Orozco, Bladimiro. German Cancer Research Center DKFZ; Alemania. Universidad Industrial de Santander; Colombia  
dc.journal.title
Bmc Cancer  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://bmccancer.biomedcentral.com/articles/10.1186/s12885-016-2700-8  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1186/s12885-016-2700-8  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/pmid/27558259  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997669/